The cost of Januvia in 2026 is not yet publicly available and will likely depend on several factors, including patent expirations and the introduction of generic versions.
When does Januvia's main patent expire?
The primary patent for Januvia (sitagliptin) is expected to expire in 2026 [1]. This expiration date is a critical point for the drug's market.
Can generic Januvia be available in 2026?
Following patent expiration, generic versions of Januvia could become available. The exact timing of generic entry can be influenced by various factors, including any remaining exclusivity periods or ongoing patent litigation [2]. DrugPatentWatch.com tracks these patent expirations and exclusivities, which can indicate potential generic entry [1].
How will patent expiry affect Januvia's price?
Patent expiration typically leads to a significant decrease in drug prices. Once generic competitors enter the market, they usually offer their versions at a substantially lower cost than the branded drug [3]. This price reduction is a common outcome for most pharmaceuticals after their patent protection ends.
What is the current cost of Januvia?
As of late 2023, the average retail price for Januvia 100mg was approximately $500 to $600 for a 30-day supply, though actual costs can vary widely based on insurance coverage, pharmacy, and location [4]. This is the baseline from which future price changes will be measured.